Compare HWKN & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HWKN | TWST |
|---|---|---|
| Founded | 1938 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.0B |
| IPO Year | 1995 | 2018 |
| Metric | HWKN | TWST |
|---|---|---|
| Price | $145.63 | $44.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $200.00 | $48.75 |
| AVG Volume (30 Days) | 112.0K | ★ 1.4M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.52% | N/A |
| EPS Growth | 12.26 | ★ 63.89 |
| EPS | ★ 3.17 | N/A |
| Revenue | ★ $974,431,000.00 | $376,572,000.00 |
| Revenue This Year | $12.37 | $18.89 |
| Revenue Next Year | $6.30 | $15.28 |
| P/E Ratio | $46.51 | ★ N/A |
| Revenue Growth | 6.01 | ★ 20.32 |
| 52 Week Low | $100.35 | $23.30 |
| 52 Week High | $186.15 | $57.88 |
| Indicator | HWKN | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 54.73 | 45.04 |
| Support Level | $142.77 | $25.67 |
| Resistance Level | $151.83 | $45.76 |
| Average True Range (ATR) | 5.11 | 2.89 |
| MACD | 0.70 | -1.05 |
| Stochastic Oscillator | 57.21 | 10.14 |
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.